HARROW INC - HROW 11 7/8 12/31/27 (HROWM) Stock Price, Quote, News and Overview
NASDAQ:HROWM - Nasdaq - US4158583074 - Currency: USD
HROWM Quote, Performance and Key Statistics
HARROW INC - HROW 11 7/8 12/31/27
NASDAQ:HROWM (5/16/2025, 8:00:01 PM)
26.235
-0.46 (-1.74%)
The current stock price of HROWM is 26.235 USD. In the past month the price decreased by -0.4%. In the past year, price decreased by -0.1%.
HROWM Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 55.04 | 718.00B | ||
| JNJ | JOHNSON & JOHNSON | 15.06 | 364.11B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 18.6 | 285.74B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.19 | 216.45B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.5 | 213.34B | ||
| MRK | MERCK & CO. INC. | 9.76 | 191.40B | ||
| PFE | PFIZER INC | 7.11 | 129.48B | ||
| SNY | SANOFI-ADR | 13.64 | 126.52B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.37 | 95.14B | ||
| GSK | GSK PLC-SPON ADR | 6.91 | 76.16B | ||
| ZTS | ZOETIS INC | 27.08 | 72.73B | ||
| HLN | HALEON PLC-ADR | 22.5 | 48.70B |
Related stock screener links
About HROWM
Company Profile
Harrow, Inc. engages in the development, production, and sale of innovative medications. The company is headquartered in Nashville, Tennessee and currently employs 382 full-time employees. The company went IPO on 2013-02-08. The firm is engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the United States market. The company provides a comprehensive portfolio of prescription and non-prescription pharmaceutical products. The company owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America, all of which are marketed under the Harrow name. The company owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical-compounding business. The company owns United States commercial rights to various products: IHEEZO, VEVYE, TRIESENCE, VIGAMOX, ILEVRO, FLAREX, NATACYN, ZERVIATE, and others. VIGAMOX (moxifloxacin hydrochloride ophthalmic solution) 0.5%, a fluoroquinolone antibiotic eye drops for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms. IHEEZO (chloroprocaine hydrochloride ophthalmic gel) 3% is a low-viscosity gel indicated for ocular surface anesthesia.
Company Info
HARROW INC - HROW 11 7/8 12/31/27
1A Burton Hills Blvd, Suite 200
Nashville TENNESSEE US
Employees: 382
Phone: 16157334731
HARROW INC - HROW 11 7/8 12/31/27 / HROWM FAQ
What is the stock price of HARROW INC - HROW 11 7/8 12/31/27 today?
The current stock price of HROWM is 26.235 USD. The price decreased by -1.74% in the last trading session.
What is the ticker symbol for HARROW INC - HROW 11 7/8 12/31/27 stock?
The exchange symbol of HARROW INC - HROW 11 7/8 12/31/27 is HROWM and it is listed on the Nasdaq exchange.
On which exchange is HROWM stock listed?
HROWM stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for HARROW INC - HROW 11 7/8 12/31/27 stock?
11 analysts have analysed HROWM and the average price target is 63.12 USD. This implies a price increase of 140.61% is expected in the next year compared to the current price of 26.235. Check the HARROW INC - HROW 11 7/8 12/31/27 stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is HARROW INC - HROW 11 7/8 12/31/27 worth?
HARROW INC - HROW 11 7/8 12/31/27 (HROWM) has a market capitalization of 962.56M USD. This makes HROWM a Small Cap stock.
How many employees does HARROW INC - HROW 11 7/8 12/31/27 have?
HARROW INC - HROW 11 7/8 12/31/27 (HROWM) currently has 382 employees.
What are the support and resistance levels for HARROW INC - HROW 11 7/8 12/31/27 (HROWM) stock?
HARROW INC - HROW 11 7/8 12/31/27 (HROWM) has a support level at 26.13 and a resistance level at 26.3. Check the full technical report for a detailed analysis of HROWM support and resistance levels.
Is HARROW INC - HROW 11 7/8 12/31/27 (HROWM) expected to grow?
The Revenue of HARROW INC - HROW 11 7/8 12/31/27 (HROWM) is expected to grow by 45.22% in the next year. Check the estimates tab for more information on the HROWM EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy HARROW INC - HROW 11 7/8 12/31/27 (HROWM) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of HROWM, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of HROWM, evaluating the profitability, health, valuation and growth aspects
- HARROW INC - HROW 11 7/8 12/31/27 (HROWM) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- HARROW INC - HROW 11 7/8 12/31/27 (HROWM) Sales and EPS estimates to see what analysts future expectations are.
- HARROW INC - HROW 11 7/8 12/31/27 (HROWM) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- HARROW INC - HROW 11 7/8 12/31/27 (HROWM) Insider and Institutional Ownership to learn about the owners and their transactions.
- HARROW INC - HROW 11 7/8 12/31/27 (HROWM) Stock Chart to make your own analysis
- HARROW INC - HROW 11 7/8 12/31/27 (HROWM) Latest news and press-releases to stay up to date.
Does HARROW INC - HROW 11 7/8 12/31/27 (HROWM) stock pay dividends?
HARROW INC - HROW 11 7/8 12/31/27 (HROWM) has a dividend yield of 11.12%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of HROWM dividend history, reliability and sustainability.
When does HARROW INC - HROW 11 7/8 12/31/27 (HROWM) report earnings?
HARROW INC - HROW 11 7/8 12/31/27 (HROWM) will report earnings on 2025-08-05, after the market close.
What is the Price/Earnings (PE) ratio of HARROW INC - HROW 11 7/8 12/31/27 (HROWM)?
HARROW INC - HROW 11 7/8 12/31/27 (HROWM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.56).
What is the Short Interest ratio of HARROW INC - HROW 11 7/8 12/31/27 (HROWM) stock?
The outstanding short interest for HARROW INC - HROW 11 7/8 12/31/27 (HROWM) is 0% of its float. Check the ownership tab for more information on the HROWM short interest.
HROWM Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to HROWM. When comparing the yearly performance of all stocks, HROWM turns out to be only a medium performer in the overall market: it outperformed 50.59% of all stocks.
HROWM Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to HROWM. HROWM has a medium profitability rating, but doesn't score so well on its financial health evaluation.
HROWM Financial Highlights
Over the last trailing twelve months HROWM reported a non-GAAP Earnings per Share(EPS) of -0.56. The EPS increased by 37.78% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.49% | ||
| ROE | -25.1% | ||
| Debt/Equity | 3.15 |
HROWM Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to HROWM. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 213.59% and a revenue growth 45.22% for HROWM